ZIOPHARM Oncology, Inc.'s Dr. Lewis to Participate as Chairman and Invited Lecturer at the 2nd Annual International Conference on Drug Discovery &Therapy, Dubai, UAE

NEW YORK--(BUSINESS WIRE)--ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that Jonathan Lewis, MD, PhD, Chief Executive Officer, has been invited to participate at the 2nd International Conference on Drug Discovery and Therapy in Dubai, United Arab Emirates as:

MORE ON THIS TOPIC